Neihulizumab (ALTB-168) in Patients With Steroid-refractory Acute Graft-versus-host Disease or Treatment-refractory Acute Graft-versus-host Disease

Clinical trial NCT03327857 · COMPLETED

Trial details

NCT number: NCT03327857
Sponsor: AltruBio Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Steroid-refractory Acute Graft-versus-Host Disease Treatment-refractory Acute Graft-versus-Host Disease

Start date: 2018-05-31
Primary completion: 2022-09-30
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.